FDA Clears an AI That Cuts False Alarms From Implantable Heart Monitors

The FDA granted 510(k) clearance to Implicity's cloud-based AI analyzer, a manufacturer-agnostic second layer that re-checks alerts from implantable cardiac monitors made by Abbott, Biotronik, Boston Scientific and Medtronic. Published research shows it cut false-positive episodes by up to 76% while keeping high sensitivity for real events, easing the review burden on cardiac care teams.